Pre‐fibrotic/early primary myelofibrosis vs. WHO‐defined essential thrombocythemia: The impact of minor clinical diagnostic criteria on the outcome of the diseaseGeorg Jeryczynski, Heinz Gisslinger, Alexander Nader et al.|American Journal of Hematology|2017Cited by 66
Clinical impact of bone marrow morphology for the diagnosis of essential thrombocythemia: comparison between the BCSH and the WHO criteriaHeinz Gisslinger, J. Thiele, Georg Jeryczynski et al.|Leukemia|2015Cited by 62
Essential thrombocythemia vs. pre-fibrotic/early primary myelofibrosis: discrimination by laboratory and clinical dataMartin Schalling, Heinz Gisslinger, Andreas Gleiß et al.|Blood Cancer Journal|2017Cited by 20
Erratum: Clinical impact of bone marrow morphology for the diagnosis of essential thrombocythemia: comparison between the BCSH and the WHO criteriaHeinz Gisslinger, J. Thiele, Georg Jeryczynski et al.|Leukemia|2017Cited by 8
Survival in Essential Thrombocythemia and Prefibrotic Primary Myelofibrosis - Correlation of Clinical Phenotype with Histomorphological DiagnosisGeorg Jeryczynski, Heinz Gisslinger, Albert Woelfler et al.|Blood|2016Cited by 0